Isolation and Functional Characterization of Side Population Stem Cells

Author(s):  
Jonathan B. Johnnidis ◽  
Fernando D. Camargo
2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Abdullah Jawad Alshawaf ◽  
Serena Viventi ◽  
Wanzhi Qiu ◽  
Giovanna D’Abaco ◽  
Bryony Nayagam ◽  
...  

2016 ◽  
Vol 10 ◽  
pp. 412-416 ◽  
Author(s):  
Emoke Pall ◽  
Sergiu Toma ◽  
Cristian Crecan ◽  
Mihai Cenariu ◽  
Ioan Groza

2018 ◽  
Vol 10 (6) ◽  
pp. 1895-1907 ◽  
Author(s):  
Thomas F. Allison ◽  
Andrew J.H. Smith ◽  
Konstantinos Anastassiadis ◽  
Jackie Sloane-Stanley ◽  
Veronica Biga ◽  
...  

2006 ◽  
Vol 104 (1) ◽  
pp. 181-186 ◽  
Author(s):  
D. A. Lawson ◽  
L. Xin ◽  
R. U. Lukacs ◽  
D. Cheng ◽  
O. N. Witte

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 4568-4568 ◽  
Author(s):  
Craig Gedye ◽  
Danylo Sirskyj ◽  
Nazleen Carol Lobo ◽  
Andrew Evans ◽  
Neil Eric Fleshner ◽  
...  

4568 Background: To study “cancer stem cells” it is imperative to account for all stromal cell populations within the tumour. The existence of “cancer stem cells” in clear cell renal cell carcinoma (ccRCC) has not been examined in ex vivo patient samples. Methods: We established a multiplex flow cytometry (FC) antibody panel in ccRCC, which reliably identified stromal lineages including CD45+ immune, CD31+/CD144+ endothelial and fibroblast-marker-positive subpopulations, thus allowing isolation of "lineage-negative" tumor cells. To verify the identity of tumour-derived populations as either cancer cells or normal stromal cells, we took advantage of the fact that mutations in VHL occur early during ccRCC tumorigenesis and are found in two-thirds of patients. Results: We sequenced 18 patient tumor samples, 12 of which had VHL exome mutations. Targeted re-sequencing of FC sorted subpopulations from these patients’ samples revealed that while CD45+ immune cells and CD31+/CD144+ endothelial cells were genetically normal, a population of VHL-mutant fibroblast-marker positive cells was consistently identified in every patient’s tumour. Immunohistochemistry showed that fibroblast marker-positive VHL-mutant cells do not have the large “clear cell” morphology typical of the majority of the cancer cells in these tumours. When purified and cultured, these fibroblast marker-positive VHL-mutant cells proliferate extensively under mesenchymal culture conditions, but displayed different morphologies to lineage-negative VHL-mutant tumor cells. Functional characterization of these FC sorted cell subpopulations is ongoing, including proliferation, migration, invasion, differentiation and treatment resistance. Conclusions: The phenotype and preliminary functional characterization of these VHL-mutant fibroblast-marker positive cells suggests a mesenchymal differentiation program in ccRCC, with implications for the ontogeny, biology and clinical management of VHL-mutant renal cancer.


2010 ◽  
Vol 25 (6) ◽  
pp. 595-604 ◽  
Author(s):  
Shiva Prasad Potta ◽  
Huamin Liang ◽  
Johannes Winkler ◽  
Michael Xavier Doss ◽  
Shuhua Chen ◽  
...  

Pancreas ◽  
2018 ◽  
Vol 47 (1) ◽  
pp. 25-34 ◽  
Author(s):  
Petra Augstein ◽  
Thomas Loudovaris ◽  
Esther Bandala-Sanchez ◽  
Peter Heinke ◽  
Gaetano Naselli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document